CONTINUE TO SITE ➞

Don't miss tomorrow's biopharma industry news

Let BioPharma Dive's free newsletter keep you informed, straight from your inbox.

Daily Dive M-F

Commercialization Weekly Every Wednesday

Gene Therapy Weekly Every Thursday

Emerging Biotech Weekly Every Tuesday

By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Deep Dive
Library
Events
Press Releases

Pharma
Biotech
FDA
Clinical Trials
Deals
Drug Pricing
Gene Therapy

What We're Reading: Page 332

Industry reads hand-picked by our editors

Aug 04, 2016

Politico
Drug lobby plans counterattack on prices
Stat
There's a possible cure for 'bubble boy' disease. It will cost $665,000
Financial Times
Theranos founder’s conference invitation sparks row among scientists
Bloomberg
Teva Chief Seeks Growth Beyond $40.5 Billion Allergan Deal

Aug 03, 2016

Boston Globe
Despite booming markets, biotech stocks remain well below their peak
The Economist
Rare diseases: fixing fate
Xconomy
More Gene Therapy Momentum as Startup Avrobio Grabs $25M From Atlas, SV
FierceBiotech
Next-gen engineered T-cell upstart nabs Regeneron option deal after Series A

Aug 02, 2016

Stat
Q&A: Glaxo exec says bioelectronics venture with Verily is ‘not science fiction’
New York Times
Setting the body's 'serial killers' loose on cancer
Bloomberg
Brexit Shock Dodged by U.K. Pharma as Innovation Spurs Deals

Aug 01, 2016

New York Times
Harnessing the Immune System to Fight Cancer
Stat
An ugly summer for science: Turmoil rocks Canadian research community
Washington Post
Britain’s scientists are freaking out over Brexit
Bloomberg
Celgene accused of using charities in 'scheme to gain billions'

Jul 29, 2016

Forbes
How Focusing On Obscure Diseases Made BioMarin A $15 Billion Company
Stat
Embattled Theranos promises first-ever peek at its science — but doubts abound
Reuters
U.S. biotech stocks win back investors in big July run
Bloomberg
AstraZeneca's Crystal Ball Is Cloudy

Jul 28, 2016

Wall Street Journal
Alere Faces Criminal Probe Over Medicare Medicaid Billing
Reuters
Ice Bucket Challenge credited with ALS breakthrough
STAT News
Rough public start for biotech founded by ex-con, as CEO fumes at ‘vicious’ press

Jul 27, 2016

The Street
Why Gilead Can't Easily Copy Celgene's 'Partner Partner Partner' Deal-Making Playbook
EP Vantage
Revlimid blow highlights big cap exposure
Regulatory Focus
FDA Lowers ANDA Fee Rates for 2017
FierceBiotech
Merck shocks ALK by returning rights to allergy immunotherapies

Previous Next

Get the free newsletter

Subscribe to BioPharma Dive for top news, trends & analysis

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.

Library resources

Trendline
Inside the world of cell therapies Supported by ProBio CDMO
Trendline
Inside the market strategies of today’s drugmakers Supported by Evaluate
Trendline
The latest developments on the gene therapy frontier Supported by Mirus Bio LLC

View all

Company Announcements

View all | Post a press release

Events

View all | Promote an event

Industry Intel

Developing an Array of Diverse Vaccine Platforms Webinar - on demand • Provided by BioPharma Dive's studioID; Sponsored content by Novavax in partnership with studioID
Top Ways that AI Will Change Life Sciences Webinar - on demand • Provided by Salesforce
Revolutionizing Next Generation Gene Therapies with On-Demand Large DNA Construct Synthesis and Novel, Designable Delivery Vehicles Webinar - on demand • Provided by Ansa Biotechnologies

Explore

About
Editorial Team
Contact Us
Newsletter
Purchase Licensing Rights
Press Releases
What We're Reading

Reach our audience

Advertising
Post a press release
Promote an event

Related Publications

Healthcare Dive
MedTech Dive

Industry Dive is an Informa TechTarget business.

This website is owned and operated by Informa TechTarget, part of a global network that informs, influences and connects the world's technology buyers and sellers. All copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. TechTarget, Inc.'s registered office is 275 Grove St. Newton, MA 02466.

Home
- Pharma
- Biotech
- FDA
- Clinical Trials
- Deals
- Drug Pricing
- Gene Therapy
Deep Dive
Library
Events
Press Releases

Get BioPharma Dive in your inbox

The free newsletter covering the top industry headlines

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.